These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34507994)

  • 1. Optimal ligand discrimination by asymmetric dimerization and turnover of interferon receptors.
    Binder P; Schnellbächer ND; Höfer T; Becker NB; Schwarz US
    Proc Natl Acad Sci U S A; 2021 Sep; 118(37):. PubMed ID: 34507994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping human interferon-alpha (IFN-alpha 2) binding determinants of the type I interferon receptor subunit IFNAR-1 with human/bovine IFNAR-1 chimeras.
    Goldman LA; Cutrone EC; Dang A; Hao X; Lim JK; Langer JA
    Biochemistry; 1998 Sep; 37(37):13003-10. PubMed ID: 9737881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural linkage between ligand discrimination and receptor activation by type I interferons.
    Thomas C; Moraga I; Levin D; Krutzik PO; Podoplelova Y; Trejo A; Lee C; Yarden G; Vleck SE; Glenn JS; Nolan GP; Piehler J; Schreiber G; Garcia KC
    Cell; 2011 Aug; 146(4):621-32. PubMed ID: 21854986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of critical residues in bovine IFNAR-1 responsible for interferon binding.
    Cutrone EC; Langer JA
    J Biol Chem; 2001 May; 276(20):17140-8. PubMed ID: 11278538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of cloned type I interferon receptor subunits to differential ligand binding.
    Cutrone EC; Langer JA
    FEBS Lett; 1997 Mar; 404(2-3):197-202. PubMed ID: 9119063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstitution of a high affinity binding site for type I interferons.
    Russell-Harde D; Pu H; Betts M; Harkins RN; Perez HD; Croze E
    J Biol Chem; 1995 Nov; 270(44):26033-6. PubMed ID: 7592797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of Ligand Specificity and Functional Plasticity in Type I Interferon Signaling.
    Kirby D; Parmar B; Fathi S; Marwah S; Nayak CR; Cherepanov V; MacParland S; Feld JJ; Altan-Bonnet G; Zilman A
    Front Immunol; 2021; 12():748423. PubMed ID: 34691060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function study of the extracellular domain of the human type I interferon receptor (IFNAR)-1 subunit.
    Kumaran J; Colamonici OR; Fish EN
    J Interferon Cytokine Res; 2000 May; 20(5):479-85. PubMed ID: 10841076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-induced association of the type I interferon receptor components.
    Cohen B; Novick D; Barak S; Rubinstein M
    Mol Cell Biol; 1995 Aug; 15(8):4208-14. PubMed ID: 7623815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-modulation of type 1 interferon responses by receptor cross-competition for a shared Jak kinase.
    Dondi E; Pattyn E; Lutfalla G; Van Ostade X; Uzé G; Pellegrini S; Tavernier J
    J Biol Chem; 2001 Dec; 276(50):47004-12. PubMed ID: 11602573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimerization of the interferon type I receptor IFNaR2-2 is sufficient for induction of interferon effector genes but not for full antiviral activity.
    Pattyn E; Van Ostade X; Schauvliege L; Verhee A; Kalai M; Vandekerckhove J; Tavernier J
    J Biol Chem; 1999 Dec; 274(49):34838-45. PubMed ID: 10574956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human interferon receptor: NMR-based modeling, mapping of the IFN-alpha 2 binding site, and observed ligand-induced tightening.
    Chill JH; Nivasch R; Levy R; Albeck S; Schreiber G; Anglister J
    Biochemistry; 2002 Mar; 41(11):3575-85. PubMed ID: 11888273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bovine type I interferon receptor protein BoIFNAR-1 has high-affinity and broad specificity for human type I interferons.
    Langer JA; Yang J; Carmillo P; Ling LE
    FEBS Lett; 1998 Jan; 421(2):131-5. PubMed ID: 9468293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of residues involved in ligand binding and signal transmission in the human IFN-alpha receptor 2.
    Chuntharapai A; Gibbs V; Lu J; Ow A; Marsters S; Ashkenazi A; De Vos A; Jin Kim K
    J Immunol; 1999 Jul; 163(2):766-73. PubMed ID: 10395669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of the IFNAR1 binding site on IFNalpha2 reveals the architecture of a weak ligand-receptor binding-site.
    Roisman LC; Jaitin DA; Baker DP; Schreiber G
    J Mol Biol; 2005 Oct; 353(2):271-81. PubMed ID: 16171819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrinsic ligand binding properties of the human and bovine alpha-interferon receptors.
    Lim JK; Xiong J; Carrasco N; Langer JA
    FEBS Lett; 1994 Aug; 350(2-3):281-6. PubMed ID: 8070579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross talk of the interferon-alpha/beta signalling complex with gp130 for effective interleukin-6 signalling.
    Mitani Y; Takaoka A; Kim SH; Kato Y; Yokochi T; Tanaka N; Taniguchi T
    Genes Cells; 2001 Jul; 6(7):631-40. PubMed ID: 11473581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for glycosphingolipid modification of the type 1 IFN receptor.
    Ghislain J; Lingwood CA; Fish EN
    J Immunol; 1994 Oct; 153(8):3655-63. PubMed ID: 7930586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-viral proteins: from interferon alpha to its receptor].
    Chieux V; Hober D; Chehadeh W; Wattr P
    Ann Biol Clin (Paris); 1999 May; 57(3):283-90. PubMed ID: 10377478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding and activity of all human alpha interferon subtypes.
    Lavoie TB; Kalie E; Crisafulli-Cabatu S; Abramovich R; DiGioia G; Moolchan K; Pestka S; Schreiber G
    Cytokine; 2011 Nov; 56(2):282-9. PubMed ID: 21856167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.